FLXN
Flexion Therapeutics Inc
Price:  
9.12 
USD
Volume:  
17,935,542.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FLXN EV/EBITDA

-388.4%
Upside

As of 2024-06-21, the EV/EBITDA ratio of Flexion Therapeutics Inc (FLXN) is -7.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FLXN's latest enterprise value is 564.21 mil USD. FLXN's TTM EBITDA according to its financial statements is -78.25 mil USD. Dividing these 2 quantities gives us the above FLXN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.0x - 17.4x 12.4x
Forward P/E multiples 15.2x - 21.9x 17.9x
Fair Price (26.35) - (29.93) (26.30)
Upside -388.9% - -428.1% -388.4%
9.12 USD
Stock Price
(26.30) USD
Fair Price

FLXN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA